一个现实世界的纵向研究,实施数字查和治疗炎症性肠病 (IBD) 的痛苦:COMPASS-IBD研究协议
Annie S K Jones1, Sophie Harding1, Natasha Seaton1
1Health Psychology Section, Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Contemporary clinical trials
|August 9, 2024
概括
这项研究实施和评估了一个数字认知行为疗法 (CBT) 计划,COMPASS-IBD,用于炎症性肠病 (IBD) 患者的焦虑和抑郁症. 这些发现将指导IBD护理中的可扩展的痛苦治疗途径.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 数字健康数字健康
背景情况:
- 同病性焦虑和抑郁 (焦虑) 对炎症性肠病 (IBD) 患者的结果产生负面影响,并增加医疗保健成本.
- 需要综合护理途径来有效地管理IBD服务中的痛苦.
- 整合常规查和数字治疗 (COMPASS-IBD) 的新途径已在英国国家卫生服务 (NHS) 的一个大型胃肠道服务中实施.
研究的目的:
- 评估一种新的综合护理途径的实施和可接受性,用于IBD患者的痛苦.
- 评估针对IBD量身定制的以治疗师为指导的数字认知行为疗法 (COMPASS-IBD) 的潜在有效性.
- 为了告知IBD应急管理的未来可扩展性和有效性.
主要方法:
- 一个混合方法,观察性,现实世界的纵向研究设计.
- 定期进行心理健康查,以确定患有痛苦的患者,然后对适当的途径进行分拣.
- 在线交付 COMPASS-IBD (12周) 治疗师支持,以及定性访谈和定量问卷以评估有效性.
主要成果:
- 实施结果集中在选采用,资格,同意和COMPASS-IBD会议完成.
- 患者和医疗保健提供者采访评估了综合护理途径的可接受性.
- 通过12周和6个月随访时的痛苦得分 (PHQ-ADS) 的变化来衡量有效性.
结论:
- 研究结果将提供关键的见解,优化治疗途径在IBD共患病的痛苦.
- 将突出提高IBD数字心理健康干预措施的可扩展性和有效性所需的调整.
- 这项研究支持将心理健康支持纳入IBD患者的常规胃肠病治疗.
更多相关视频
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:17Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436
01:30Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
154
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154